Carolyn Grove

3.2k total citations · 1 hit paper
29 papers, 1.3k citations indexed

About

Carolyn Grove is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Carolyn Grove has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 13 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Carolyn Grove's work include Acute Myeloid Leukemia Research (18 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Carolyn Grove is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Carolyn Grove collaborates with scholars based in Australia, United Kingdom and Spain. Carolyn Grove's co-authors include George S. Vassiliou, Gary Lee, Roland Rad, Ignacio Varela, Michael A. Quail, Charles Crawley, Thomas McKerrell, Mike Scott, Thaidy Moreno-Rodriguez and Hannes Ponstingl and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Carolyn Grove

28 papers receiving 1.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis

2015 357 citations Thomas McKerrell, Naomi Park et al. Cell Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carolyn Grove Australia	14	772	721	295	211	128	29	1.3k
F Viguié France	21	844 1.1×	861 1.2×	273 0.9×	206 1.0×	302 2.4×	45	1.6k
Yosuke Minami Japan	22	812 1.1×	802 1.1×	355 1.2×	148 0.7×	395 3.1×	103	1.6k
Esther A. Obeng United States	12	584 0.8×	1.2k 1.7×	160 0.5×	146 0.7×	303 2.4×	33	1.8k
Amanda Winters United States	15	1.1k 1.4×	999 1.4×	177 0.6×	268 1.3×	250 2.0×	39	1.6k
Albertus T.J. Wierenga Netherlands	22	431 0.6×	659 0.9×	155 0.5×	255 1.2×	374 2.9×	34	1.3k
Maria Kleppe United States	13	361 0.5×	459 0.6×	302 1.0×	128 0.6×	230 1.8×	24	947
Anja Vales Austria	20	282 0.4×	433 0.6×	187 0.6×	115 0.5×	91 0.7×	30	1.0k
Andreas Tobler Switzerland	24	332 0.4×	705 1.0×	204 0.7×	127 0.6×	394 3.1×	49	1.2k
Kumiko Goi Japan	21	341 0.4×	665 0.9×	148 0.5×	178 0.8×	356 2.8×	78	1.2k

Countries citing papers authored by Carolyn Grove

Since Specialization

Citations

This map shows the geographic impact of Carolyn Grove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolyn Grove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolyn Grove more than expected).

Fields of papers citing papers by Carolyn Grove

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolyn Grove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolyn Grove. The network helps show where Carolyn Grove may publish in the future.

Co-authorship network of co-authors of Carolyn Grove

This figure shows the co-authorship network connecting the top 25 collaborators of Carolyn Grove. A scholar is included among the top collaborators of Carolyn Grove based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolyn Grove. Carolyn Grove is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wilson, Lynne, Rebecca Howman, Carolyn Grove, et al.. (2024). Transcription factor 3 is dysregulated in megakaryocytes in myelofibrosis. Platelets. 35(1). 2304173–2304173. 2 indexed citations

Kremyanskaya, Marina, Lee Ping Chew, Hanlon Sia, et al.. (2024). Initial Results from a Phase 1/2 Study Evaluating Divesiran, a Novel Galnac Conjugated siRNA, in Patients with Polycythemia Vera (SANRECO). Blood. 144(Supplement 1). 656–656. 1 indexed citations

Samaraweera, Saumya E., Tatjana Geukens, Débora A. Casolari, et al.. (2022). Novel modes of MPL activation in triple-negative myeloproliferative neoplasms. Pathology. 55(1). 77–85. 1 indexed citations

Chua, Chong Chyn, Natasha S. Anstee, Anoop Enjeti, et al.. (2022). High Deliverability of a Midostaurin Triplet Regimen Incorporating Venetoclax and Low Dose Cytarabine in Non-Adverse Cytogenetic Risk Acute Myeloid Leukaemia: A Sub-Analysis of the Australasian Leukaemia Lymphoma Group (ALLG) Intervene Study. Blood. 140(Supplement 1). 3362–3364. 5 indexed citations

Ross, David M., Nada Hamad, Steven Lane, et al.. (2021). Myeloid somatic mutation panel testing in myeloproliferative neoplasms. Pathology. 53(3). 339–348. 11 indexed citations

Botton, Stéphane de, Karen Yee, Christian Récher, et al.. (2021). Effect of olutasidenib (FT-2102) on complete remissions in patients with relapsed/refractory (R/R) mIDH1 acute myeloid leukemia (AML): Results from a planned interim analysis of a phase 2 clinical trial.. Journal of Clinical Oncology. 39(15_suppl). 7006–7006. 8 indexed citations

Stafford, Andrew, et al.. (2020). Outcomes and anticoagulation use for elderly patients that present with an acute hip fracture: multi‐centre, retrospective analysis. Internal Medicine Journal. 52(3). 418–425. 12 indexed citations

Friedrich, Mathias, Lena Rad, Iraad F. Bronner, et al.. (2017). Genome-wide transposon screening and quantitative insertion site sequencing for cancer gene discovery in mice. Nature Protocols. 12(2). 289–309. 26 indexed citations

Dovey, Oliver M., Jonathan Cooper, Annalisa Mupo, et al.. (2017). Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia. Blood. 130(17). 1911–1922. 52 indexed citations

10.

Kühn, Michael W.M., E Song, Zhaohui Feng, et al.. (2016). Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia. Cancer Discovery. 6(10). 1166–1181. 166 indexed citations

11.

McKerrell, Thomas, Naomi Park, Thaidy Moreno-Rodriguez, et al.. (2015). Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis. Cell Reports. 10(8). 1239–1245. 357 indexed citations breakdown →

12.

Bolli, Niccolò, Nicla Manes, Thomas McKerrell, et al.. (2014). Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol. Haematologica. 100(2). 214–222. 37 indexed citations

13.

Taylor, Samuel J., Christine B.F. Thien, Carolyn Grove, et al.. (2014). Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant mice. Experimental Hematology. 43(3). 191–206.e1. 13 indexed citations

14.

Gangatharan, Shane, Carolyn Grove, John O’Reilly, et al.. (2013). Acute myeloid leukaemia in Western Australia 1991–2005: a retrospective population‐based study of 898 patients regarding epidemiology, cytogenetics, treatment and outcome. Internal Medicine Journal. 43(8). 903–911. 20 indexed citations

15.

Conte, Nathalie, Ignacio Varela, Carolyn Grove, et al.. (2013). Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture. Leukemia. 27(9). 1820–1825. 22 indexed citations

16.

Vassiliou, George S., Jonathan Cooper, Roland Rad, et al.. (2011). Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice. Nature Genetics. 43(5). 470–475. 150 indexed citations

17.

Grove, Carolyn, George Follows, & Wendy N. Erber. (2009). Incidental finding of lymphocytosis in an asymptomatic patient. BMJ. 338(jun10 1). b2119–b2119. 2 indexed citations

18.

Grove, Carolyn, Peter Robbins, & Allan G. Kermode. (2008). Intravascular lymphoma presenting as progressive paraparesis. Journal of Clinical Neuroscience. 15(9). 1056–1058. 10 indexed citations

19.

Misso, Neil L.A., et al.. (2007). Plasma phospholipase A2 activity in patients with asthma: association with body mass index and cholesterol concentration. Thorax. 63(1). 21–26. 21 indexed citations

20.

Grove, Carolyn & Gary Lee. (2002). Vascular endothelial growth factor: the key mediator in pleural effusion formation. Current Opinion in Pulmonary Medicine. 8(4). 294–301. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact